OKUR
OnKure Therapeutics, Inc.
NASDAQ: OKUR · HEALTHCARE · BIOTECHNOLOGY
$3.44
-12.02% today
Updated 2026-05-11
Market cap
$157.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$2 – $5
Volume
0.3M
OnKure Therapeutics, Inc. (OKUR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-42.70%
ROA
-25.80%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-19.46M | — | — | — |
| 2021 | — | $-39.77M | — | — | — |
| 2022 | $0.00 | $-29.51M | — | — | — |
| 2023 | $0.00 | $-35.31M | — | — | — |
| 2024 | $0.00 | $-52.67M | — | — | — |
| 2025 | $0.00 | $-59.52M | — | — | — |